Company Filing History:
1 out of 1,552 
1 out of 2 Years Active: 2011
Title: Tim Keen: Innovator in HIV Vaccine Development
Introduction
Tim Keen is an accomplished inventor based in the United States, known for his contributions to the field of HIV vaccine development. His innovative work focuses on creating effective vaccination methods to combat HIV, a virus that continues to pose significant health challenges worldwide.
Latest Patents
Tim Keen holds a notable patent titled "Polyvalent, Primary HIV-1 Glycoprotein DNA Vaccines and Vaccination Methods." This patent discloses polyvalent, primary isolate nucleic acid compositions designed to induce an immune response against HIV. The compositions and methods described involve a DNA composition that encodes one or more different HIV envelope glycoproteins, including the HIV Gag protein. The DNA sequences are derived from primary isolate DNA of various HIV major group genetic clades, allowing for a comprehensive approach to vaccine development.
Career Highlights
Throughout his career, Tim Keen has worked with prestigious institutions, including the University of Massachusetts and Advanced Bioscience Laboratories, Inc. His research has significantly advanced the understanding of HIV and the development of effective vaccines.
Collaborations
Tim Keen has collaborated with notable colleagues in the field, including Shan Lu and Shixia Wang. Their combined expertise has contributed to the progress of HIV research and vaccine innovation.
Conclusion
Tim Keen's work in HIV vaccine development exemplifies the importance of innovation in addressing global health challenges. His contributions continue to inspire advancements in medical research and public health initiatives.